Refractory Childhood Neuroblastoma
1 clinical trials · Condition
◉ Watch Refractory Childhood Neuroblastoma
| Record | Firm | Date |
|---|---|---|
| Testing a New Immune Cell Therapy, GD2-Targeted Modified T-cells (GD2CART), in Children, Adolescents, and Young Adults With Relapsed/Refractory Osteosarcoma and Neuroblastoma, GD2-CAR PERSIST Trial (NCT04539366) | National Cancer Institute (NCI) | 2022-01-25 |
Track Refractory Childhood Neuroblastoma automatically
Every clearance here is in the API, with alerts when new ones post.